PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
10764626-1	2000	The P-glycoprotein (P-gp)-negative epidermoid pharyngeal carcinoma cells KB-3-1 were grown in 0.25 mM benzo[a]pyrene (BaP) for 3 months and increased resistance to doxorubicin, but not to vinblastine, colchicine, or cisplatin, was found.	Benzo(a)pyrene	102-116	ATP binding cassette subfamily B member 1	Homo sapiens	4-18	
10764626-3	2000	Intracellular accumulation of BaP or calcein, a substrate for P-gp and multidrug resistance protein (MRP), was not altered by inhibitors of the P-gp and MRP.	Benzo(a)pyrene	30-33	ATP binding cassette subfamily B member 1	Homo sapiens	62-66	
10764626-6	2000	BaP-treated KB-3-1 cells remained P-gp negative while the level of MRP was not altered.	Benzo(a)pyrene	0-3	ATP binding cassette subfamily B member 1	Homo sapiens	34-38	
7903198-2	1993	We previously showed that MDR cells derived from exposure to Adriamycin are cross-resistant to a chemical carcinogen, benzo(a)pyrene, due to its cellular efflux by the P-gp-mediated putative drug efflux pump.	Benzo(a)pyrene	118-132	ATP binding cassette subfamily B member 1	Homo sapiens	168-172	
16647797-0	2006	Effect of benzo[a]pyrene on P-glycoprotein-mediated transport in Caco-2 cell monolayer.	Benzo(a)pyrene	10-24	ATP binding cassette subfamily B member 1	Homo sapiens	28-42	
9272928-1	1997	MDR1 P-glycoprotein (Pgp 170), a member of the adenosine triphosphate (ATP) binding cassette transporters, acts as an efflux pump for various hydrophobic agents, particularly for xenobiotics such as benzo(a)pyrene.	Benzo(a)pyrene	199-213	ATP binding cassette subfamily B member 1	Homo sapiens	0-4	
9272928-1	1997	MDR1 P-glycoprotein (Pgp 170), a member of the adenosine triphosphate (ATP) binding cassette transporters, acts as an efflux pump for various hydrophobic agents, particularly for xenobiotics such as benzo(a)pyrene.	Benzo(a)pyrene	199-213	ATP binding cassette subfamily B member 1	Homo sapiens	5-19	
17408918-0	2007	Effects of benzo(e)pyrene and benzo(a)pyrene on P-glycoprotein-mediated transport in Caco-2 cell monolayer: a comparative approach.	Benzo(a)pyrene	30-44	ATP binding cassette subfamily B member 1	Homo sapiens	48-62	
17408918-1	2007	The previous studies from our laboratory reported that benzo(a)pyrene (Bap) influenced efflux transport of rhodamine 123 (Rho-123) by induction of P-glycoprotein (P-gp) in Caco-2 cells.	Benzo(a)pyrene	55-69	ATP binding cassette subfamily B member 1	Homo sapiens	147-161	
17408918-1	2007	The previous studies from our laboratory reported that benzo(a)pyrene (Bap) influenced efflux transport of rhodamine 123 (Rho-123) by induction of P-glycoprotein (P-gp) in Caco-2 cells.	Benzo(a)pyrene	55-69	ATP binding cassette subfamily B member 1	Homo sapiens	163-167	
17408918-1	2007	The previous studies from our laboratory reported that benzo(a)pyrene (Bap) influenced efflux transport of rhodamine 123 (Rho-123) by induction of P-glycoprotein (P-gp) in Caco-2 cells.	Benzo(a)pyrene	71-74	ATP binding cassette subfamily B member 1	Homo sapiens	147-161	
17408918-1	2007	The previous studies from our laboratory reported that benzo(a)pyrene (Bap) influenced efflux transport of rhodamine 123 (Rho-123) by induction of P-glycoprotein (P-gp) in Caco-2 cells.	Benzo(a)pyrene	71-74	ATP binding cassette subfamily B member 1	Homo sapiens	163-167	
17408918-8	2007	Our results further show that Bep or Bap-induced P-gp in Caco-2 cells might have been the result of oxidative stress rather than DNA damage.	Benzo(a)pyrene	37-40	ATP binding cassette subfamily B member 1	Homo sapiens	49-53